Menter A - Search Results

1

Utilization of narrow-band ultraviolet light B therapy and etanercept for the treatment of psoriasis (UNITE): efficacy, safety, and patient-reported outcomes.

Kircik L, Bagel J, Korman N, Menter A, Elmets CA, Koo J, Yang YC, Chiou CF, Dann F, Stevens SR; Unite Study Group. Kircik L, et al. Among authors: menter a. J Drugs Dermatol. 2008 Mar;7(3):245-53. J Drugs Dermatol. 2008. PMID: 18380206 Clinical Trial.

2

Two considerations for patients with psoriasis and their clinicians: what defines mild, moderate, and severe psoriasis? What constitutes a clinically significant improvement when treating psoriasis?

Krueger GG, Feldman SR, Camisa C, Duvic M, Elder JT, Gottlieb AB, Koo J, Krueger JG, Lebwohl M, Lowe N, Menter A, Morison WL, Prystowsky JH, Shupack JL, Taylor JR, Weinstein GD, Barton TL, Rolstad T, Day RM. Krueger GG, et al. Among authors: menter a. J Am Acad Dermatol. 2000 Aug;43(2 Pt 1):281-5. doi: 10.1067/mjd.2000.106374. J Am Acad Dermatol. 2000. PMID: 10906652

3

The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership survey.

Krueger G, Koo J, Lebwohl M, Menter A, Stern RS, Rolstad T. Krueger G, et al. Among authors: menter a. Arch Dermatol. 2001 Mar;137(3):280-4. Arch Dermatol. 2001. PMID: 11255325

4

Consensus conference: acitretin in combination with UVB or PUVA in the treatment of psoriasis.

Lebwohl M, Drake L, Menter A, Koo J, Gottlieb AB, Zanolli M, Young M, McClelland P. Lebwohl M, et al. Among authors: menter a. J Am Acad Dermatol. 2001 Oct;45(4):544-53. doi: 10.1067/mjd.2001.116347. J Am Acad Dermatol. 2001. PMID: 11568745 Review.

5

A randomized, double-blind, placebo-controlled study of clobetasol propionate 0.05% foam in the treatment of nonscalp psoriasis.

Lebwohl M, Sherer D, Washenik K, Krueger GG, Menter A, Koo J, Feldman SR. Lebwohl M, et al. Among authors: menter a. Int J Dermatol. 2002 May;41(5):269-74. doi: 10.1046/j.1365-4362.2002.01431.x. Int J Dermatol. 2002. PMID: 12100701 Clinical Trial.

6

Repeat courses of intravenous alefacept in patients with chronic plaque psoriasis provide consistent safety and efficacy.

Lowe NJ, Gonzalez J, Bagel J, Caro I, Ellis CN, Menter A. Lowe NJ, et al. Among authors: menter a. Int J Dermatol. 2003 Mar;42(3):224-30. doi: 10.1046/j.1365-4362.2003.01793.x. Int J Dermatol. 2003. PMID: 12653922 Free article. Clinical Trial.

7

Case studies in severe psoriasis: A clinical strategy.

Lebwohl M, Menter A, Koo J, Feldman S. Lebwohl M, et al. Among authors: menter a. J Dermatolog Treat. 2003;14 Suppl 2:26-46. doi: 10.1080/jdt.14.s2.26.46. J Dermatolog Treat. 2003. PMID: 14578096 Free article.

8

Impact of efalizumab on psoriasis-specific patient-reported outcomes. Results from three randomized, placebo-controlled clinical trials of moderate to severe plaque psoriasis.

Menter A, Kosinski M, Bresnahan BW, Papp KA, Ware JE Jr. Menter A, et al. J Drugs Dermatol. 2004 Jan-Feb;3(1):27-38. J Drugs Dermatol. 2004. PMID: 14964744 Clinical Trial.

9

Combination therapy to treat moderate to severe psoriasis.

Lebwohl M, Menter A, Koo J, Feldman SR. Lebwohl M, et al. Among authors: menter a. J Am Acad Dermatol. 2004 Mar;50(3):416-30. doi: 10.1016/j.jaad.2002.12.002. J Am Acad Dermatol. 2004. PMID: 14988684 Review.

10

Improved health-related quality of life following a randomized controlled trial of alefacept treatment in patients with chronic plaque psoriasis.

Feldman SR, Menter A, Koo JY. Feldman SR, et al. Among authors: menter a. Br J Dermatol. 2004 Feb;150(2):317-26. doi: 10.1111/j.1365-2133.2004.05697.x. Br J Dermatol. 2004. PMID: 14996104 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

384 results

Search Page

Filters